Cargando…

Drug Strategies Targeting CYP51 in Neglected Tropical Diseases

Detalles Bibliográficos
Autores principales:	Choi, Jun Yong, Podust, Larissa M., Roush, William R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254036/ https://www.ncbi.nlm.nih.gov/pubmed/25337991 http://dx.doi.org/10.1021/cr5003134

Ejemplares similares

Binding Mode and Potency of N-Indolyloxopyridinyl-4-aminopropanyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51
por: Vieira, Debora F., et al.
Publicado: (2014)

CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)
por: Debnath, Anjan, et al.
Publicado: (2017)

4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency
por: Calvet, Claudia M., et al.
Publicado: (2014)

Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51
por: Gunatilleke, Shamila S., et al.
Publicado: (2012)

Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
por: Chen, Chiung-Kuang, et al.
Publicado: (2010)

4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection
por: Calvet, Claudia Magalhaes, et al.
Publicado: (2017)

Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit
por: Chen, Chiung-Kuang, et al.
Publicado: (2009)

Machine learning and drug discovery for neglected tropical diseases
por: Breslin, William, et al.
Publicado: (2023)

Who Neglects Neglected Tropical Diseases? - Korean Perspective
por: Choi, Min-Ho, et al.
Publicado: (2015)

To end the neglect of neglected tropical diseases
por: The Lancet Regional Health – Western Pacific
Publicado: (2022)

Social sciences research in neglected tropical diseases 1: the ongoing neglect in the neglected tropical diseases
por: Allotey, Pascale, et al.
Publicado: (2010)

Neglected Tropical Diseases outside the Tropics
por: Norman, Francesca F., et al.
Publicado: (2010)

Neglected tropical diseases
por: Molyneux, David
Publicado: (2013)

Neglected tropical diseases
por: Parija, Subhash Chandra
Publicado: (2022)

Neglected Testing for Neglected Tropical Diseases at the CDC
por: Beatty, Norman L., et al.
Publicado: (2022)

Innovation in neglected tropical disease drug discovery and development
por: Weng, Hong-Bo, et al.
Publicado: (2018)

Ending the “Neglect” to End Neglected Tropical Diseases
por: Yang, Pin, et al.
Publicado: (2022)

Histone deacetylase enzymes as potential drug targets of Neglected Tropical Diseases caused by cestodes
por: Vaca, Hugo R., et al.
Publicado: (2019)

Neglected Tropical Diseases, Neglected Data Sources, and Neglected Issues
por: Singer, Burton H., et al.
Publicado: (2007)

Exploring Cryptococcus neoformans CYP51 and Its Cognate Reductase as a Drug Target
por: Ruma, Yasmeen N., et al.
Publicado: (2022)

Neglected tropical disease targets must include morbidity
por: Deribe, Kebede
Publicado: (2015)

The untapped cell biology of neglected tropical diseases
por: Sullivan, William
Publicado: (2016)

Treating neglected tropical diseases
por: Hopkins, Adrian
Publicado: (2013)

India’s neglected tropical diseases
por: Hotez, Peter J., et al.
Publicado: (2018)

Neglected Tropical Diseases in Lebanon
por: Alam, Walid, et al.
Publicado: (2022)

Why is noma a neglected-neglected tropical disease?
por: Srour, M. Leila, et al.
Publicado: (2020)

Neglected Tropical Diseases in Pakistan: A Story of Neglect
por: KHAN, Aisha, et al.
Publicado: (2020)

Fostering Canadian drug research and development for neglected tropical diseases
por: Gabriel, Patricia, et al.
Publicado: (2010)

Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis
por: Shrivastav, Manish T., et al.
Publicado: (2021)

Editorial: Cheminformatics Approaches in Drug Discovery for Neglected Tropical Diseases
por: Scotti, Luciana, et al.
Publicado: (2021)

Characterisation of Candida parapsilosis CYP51 as a Drug Target Using Saccharomyces cerevisiae as Host
por: Ruma, Yasmeen N., et al.
Publicado: (2022)

Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model
por: Dauchy, Frédéric-Antoine, et al.
Publicado: (2016)

The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors
por: Zhang, Jingxiang, et al.
Publicado: (2019)

Zoonotic Larval Cestode Infections: Neglected, Neglected Tropical Diseases?
por: Budke, Christine M., et al.
Publicado: (2009)

Deleting the ‘neglect’ from two neglected tropical diseases in India
por: Kant, Lalit
Publicado: (2016)

Effectiveness of Mass Drug Administration on Neglected Tropical Diseases in Schoolchildren in Zanzibar, Tanzania
por: Kim, Ju Yeong, et al.
Publicado: (2020)

People are neglected, not diseases: the relationship between disability and neglected tropical diseases
por: Hamill, Louise Claire, et al.
Publicado: (2019)

Aboriginal Populations and Their Neglected Tropical Diseases
por: Hotez, Peter J.
Publicado: (2014)

Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases
por: Volpedo, Greta, et al.
Publicado: (2019)

Supporting Drug Development for Neglected Tropical Diseases Using Mathematical Modeling
por: Walker, Martin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t138190k4nuamvgt14ljt9ej41